Annette Young+FollowArrowhead’s Weight Loss Combo Just Doubled ResultsArrowhead Pharma just crashed the obesity drug party—its new RNAi therapy, when paired with Lilly’s tirzepatide, doubled the weight loss seen with tirzepatide alone in early trials. Not only that, but it slashed more of the stubborn visceral and liver fat that really matters for metabolic health. The catch? It’s early days and only a handful of patients, but Wall Street is already hyped. Could this be the next big thing in weight loss meds? #Fitness #weightloss #obesity00Share
Jennifer Price+FollowObesity Redefined: Are We All at Risk?Turns out, the way we measure obesity just got a major upgrade—and it’s wild. Researchers say if we use waist size along with BMI, over 75% of U.S. adults would be considered obese (yep, almost double the old estimate). Even people with a 'normal' BMI could be at risk. This could totally change how we think about health, diets, and even who gets weight-loss meds. Are you surprised by these new numbers? #Fitness #Obesity #HealthNews20Share
Jennifer Wilson+FollowOne-Shot Obesity Drug Melts Belly FatThis new obesity drug from Wave Life Sciences is wild—a single shot (no diet or exercise changes!) slashed dangerous visceral fat by 9.4% in just three months and even boosted lean muscle. The best part? It’s safe, well-tolerated, and the effects could last for months. Could this be the future of weight loss? Stock soared 133% after the news dropped. Would you try a once-a-year fat-busting shot? #Health #BodyHealth #Obesity4313Share
BikiniGirl+FollowI'm a “skinny” woman from a fat family, Ask Me Anything!I'm here to answer your questions about... what it really takes to not be fat. Most of what you’re told is nonsense. #obesity #skinny #bikinibody #CommunityAMA5774Share
